Find-Health-Articles.com - making medical research available to everyone

Drug Synergism
Research News and Information

Saturday, November 21, 2009

Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection.

29 Nov 2009 It has been reported that polymorphisms of human leukocyte antigen (HLA) genes and several cytokine genes are associated with an increased risk of developing gastric cancer (GC). However, the results of studies from different geographic regions, ... Read more...


Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models.

29 Nov 2009 Lonafarnib is a potent, selective farnesyltransferase inhibitor (FTI) undergoing clinical studies for the treatment of solid tumors and hematological malignancies. Preclinically, a number of FTIs, including lonafarnib, interact with taxanes to ... Read more...


Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.

13 Nov 2009 New treatment approaches are needed for hormone refractory prostate cancer. Oncolytic adenoviruses are promising anti-cancer agents, and their efficacy can be improved by combining with conventional therapies such as ionizing radiation. The aim of ... Read more...

 

Latest indexed articles for 'Drug Synergism'

These are the very latest articles for this heading:

See a longer list of these articles.

Technical information about 'Drug Synergism'

Descriptor UI: D004357

Alternative terms: Drug Synergism; Drug Synergisms; Synergism, Drug; Synergisms, Drug; Drug Potentiation; Drug Potentiations; Potentiation, Drug; Potentiations, Drug;

Related Mesh Headings: Cocarcinogenesis; Pesticide Synergists;

Tree Number: G07.690.812.240.477; G07.700.680.240.477;

History Note: 66(65)

Technical Notes: IM when general; NIM when with specific drugs (IM); no qualif

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index